Apalutamide, enzalutamide, and darolutamide for non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis
Titel:
Apalutamide, enzalutamide, and darolutamide for non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis
Auteur:
Mori, Keiichiro Mostafaei, Hadi Pradere, Benjamin Motlagh, Reza Sari Quhal, Fahad Laukhtina, Ekaterina Schuettfort, Victor M. Abufaraj, Mohammad Karakiewicz, Pierre I. Kimura, Takahiro Egawa, Shin Shariat, Shahrokh F.